An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty

• Sponsor: University of Arkansas (Other)
• Overall Status: Completed
• CT.gov ID: NCT03071250
• Collaborator: (none)
• Enrollment: 500
• Location: 1
• Actual Duration (Months): 9
• Patients Per Site Per Month: 55.7

Study Details

Study Description

Brief Summary

The care for patients receiving total hip and knee arthroplasty at the University of Arkansas for Medical Sciences has followed a structured care pathway since July 2015. This system of perioperative care has focused on preoperative assessment of medical co-morbidities and risks to postoperative functional recovery, anesthetic care focused on postoperative nausea and vomiting prevention and optimizing immediate postoperative functional ability, and aggressive postoperative physical therapy.

This is an observational study to look at the outcomes of this program at University of Arkansas for Medical Sciences. Areas of focus will be hospital length of stay, postoperative narcotic consumption, Visual Analog Scale scores, incidence of postoperative nausea and vomiting, and 30-day readmission rates, and health literacy rates.

Condition or Disease	Intervention/Treatment	Phase
Knee Osteoarthritis; Hip Osteoarthritis; Knee Arthritis; Hip Arthritis	Procedure: Total knee or Hip Arthroplasty

Study Design

• Study Type: Observational
• Actual Enrollment: 500 participants
• Observational Model: Cohort
• Time Perspective: Retrospective
• Official Title: An Analysis of the Outcomes From Protocolized Perioperative Care for Patients Receiving Total Hip or Knee Arthroplasty
• Actual Study Start Date: Oct 1, 2018
• Actual Primary Completion Date: Jun 1, 2019
• Actual Study Completion Date: Jul 1, 2019

Outcome Measures

Primary Outcome Measures

1. Length of Stay [7/1/2015 - 7/1/2016]

   Postoperative hospital length of stay

Secondary Outcome Measures

1. narcotic consumption [7/1/2015 - 7/1/2016]

   30-day postoperative narcotic consumption

2. Pain scores [7/1/2015 - 7/1/2016]

   postoperative VAS pain scores

3. 30-day readmission [7/1/2015 - 7/1/2016]

   30-day hospital readmission following procedure

4. infection [7/1/2015 - 7/1/2016]

   Surgical site infections

5. PONV [7/1/2015 - 7/1/2016]

   postoperative nausea and vomiting

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years and Older
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• All men and women 18 years and older who underwent total hip arthroplasty or total knee arthroplasty surgery at UAMS between 7/01/2015 and 7/01/2016.

Exclusion Criteria:

• none

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	University of Arkansas for MEdical Sciences	Little Rock	Arkansas	United States	72205

Sponsors and Collaborators

• University of Arkansas

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: University of Arkansas
• ClinicalTrials.gov Identifier: NCT03071250
• Other Study ID Numbers: 206501
• First Posted: Mar 6, 2017
• Last Update Posted: Jul 24, 2019
• Last Verified: Jul 1, 2019

• Individual Participant Data (IPD) Sharing Statement: No
• Plan to Share IPD: No
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Arthritis; Osteoarthritis; Osteoarthritis, Knee; Osteoarthritis, Hip

Study Results

No Results Posted as of Jul 24, 2019